Melior Pharmaceuticals   Report issue

For profit Phase 2
Founded: Exton PA United States (2010)

Organization Overview

First Clinical Trial
2014
NCT02317796
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Melior Pharmaceuticals | Melior Pharmaceuticals I & Bukwang Pharm. Co., Ltd. | Melior Pharmaceuticals, Inc.